Zhengye Biotechnology (ZYBT) director Jiang Ping files initial Form 3

Rhea-AI Filing Summary

Zhengye Biotechnology Holding Ltd director Jiang Ping (PiJi) filed an initial Form 3 ownership report for ticker ZYBT. The filing lists Jiang Ping as a director but not a ten percent owner, and shows no reported purchases, sales, or other transactions in the company’s securities.

Key Figures

Net buy/sell shares: 0 shares Buy transactions: 0 Sell transactions: 0

3 metrics

Net buy/sell shares 0 shares Form 3 transactionSummary netBuySellShares

Buy transactions 0 Form 3 transactionSummary buyCount and buyShares

Sell transactions 0 Form 3 transactionSummary sellCount and sellShares

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/25/2026 - 11:39 AM Accepted by SEC EDGAR 06/25/2026 - 11:38 AM Learn about SEC filing dates

FAQ

What does the ZYBT Form 3 filing by Jiang Ping (PiJi) show?

The Form 3 shows that Jiang Ping (PiJi) is a director of Zhengye Biotechnology Holding Ltd. It reports no purchases, sales, or other transactions, and indicates Jiang Ping is not classified as a ten percent owner in this initial ownership statement.

Is Jiang Ping (PiJi) a ten percent owner of Zhengye Biotechnology (ZYBT)?

No, the filing indicates Jiang Ping (PiJi) is not a ten percent owner of Zhengye Biotechnology Holding Ltd. The status flags show directorship only, with the ten percent owner indicator set to zero in this Form 3 ownership disclosure.

Does the ZYBT Form 3 include any insider buying or selling activity?

No insider buying or selling is reported. The transaction summary shows zero buys, zero sells, and zero derivative exercises, indicating this Form 3 serves purely as an initial ownership statement without any concurrent transactions disclosed.

What role does Jiang Ping (PiJi) hold at Zhengye Biotechnology Holding Ltd?

Jiang Ping (PiJi) is identified as a director of Zhengye Biotechnology Holding Ltd. In the Form 3 data, the director flag is set to one, while officer and ten percent owner fields are not marked, clarifying the reported governance role.

Are there any derivative positions reported for Jiang Ping (PiJi) in ZYBT?

No derivative positions are reported. The derivative summary is empty and the derivative transaction count is zero, meaning there are no listed stock options, warrants, or other derivative securities for Jiang Ping (PiJi) in this Form 3 snapshot.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Jiang Ping (PiJi)

(Last) (First) (Middle)

NO.1 LIANMENG ROAD

(Street)

JILIN CITY JILIN PROVINCE 132101

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/25/2026

3. Issuer Name and Ticker or Trading Symbol
Zhengye Biotechnology Holding Ltd [ ZYBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Ping Jiang	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)